Powder: -20°C for 3 years | In solvent: -80°C for 1 year
AMPK activator 4 是一种有效且具有选择性的AMPK激活剂,不抑制线粒体复合物 I。AMPK activator 4 选择性地激活肌肉组织中的 AMPK且剂量依赖性地改善正常小鼠的糖耐量,显著降低 db/db 糖尿病小鼠的空腹血糖水平和改善胰岛素抵抗。AMPK activator 4 具有降血糖作用。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 943 | 现货 | ||
5 mg | ¥ 1,920 | 现货 | ||
10 mg | ¥ 3,730 | 现货 | ||
25 mg | ¥ 5,910 | 现货 | ||
50 mg | ¥ 8,330 | 现货 | ||
100 mg | ¥ 11,200 | 现货 | ||
500 mg | ¥ 22,500 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 2,280 | 现货 |
产品描述 | AMPK activator 4 is a potent and selective AMPK activator that does not inhibit mitochondrial complex I. AMPK activator 4 selectively activates AMPK in muscle tissue and dose-dependently improves glucose tolerance in normal mice, significantly reduces fasting glucose levels and improves insulin resistance in db/db diabetic mice.AMPK activator 4 has hypoglycemic effects. activator 4 has hypoglycemic effects. |
体外活性 |
AMPK activator 4 (compound B10) (10-20 μM; 72 h) slightly decreases the viability of HepG2 cells.[1] AMPK activator 4 (0-20 μM; 12-24 h) induced dose-dependent phosphorylation of ACC in C2C12 myotube cells, and the phosphorylation of ACC was highly consistent with the phosphorylation of AMPK. Increased the phosphorylation of AMPK and ACC in human hepatocarcinoma HepG2 and HuH-7 cells.[1] |
体内活性 | AMPK activator 4 (100 mg/kg; Intragastrical administration; daily for 9 weeks; db/db mice) significantly lowered the fasting blood glucose in db/db mice (2-6 weeks). Significantly improved insulin resistance in db/db mice (for 9 weeks). The body weight and the serum levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) (two markers of liver injury) were not significantly affected. It shows an anti-hyperglycemic effect.[1] |
分子量 | 420.89 |
分子式 | C24H21ClN2O3 |
CAS No. | 2493239-46-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 50 mg/mL (118.8 mM), Sonication is recommended.
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.3759 mL | 11.8796 mL | 23.7592 mL | 59.3979 mL |
5 mM | 0.4752 mL | 2.3759 mL | 4.7518 mL | 11.8796 mL | |
10 mM | 0.2376 mL | 1.188 mL | 2.3759 mL | 5.9398 mL | |
20 mM | 0.1188 mL | 0.594 mL | 1.188 mL | 2.9699 mL | |
50 mM | 0.0475 mL | 0.2376 mL | 0.4752 mL | 1.188 mL | |
100 mM | 0.0238 mL | 0.1188 mL | 0.2376 mL | 0.594 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
AMPK activator 4 2493239-46-4 Chromatin/Epigenetic PI3K/Akt/mTOR signaling AMPK Inhibitor inhibitor inhibit